Revelation Biosciences, Inc. Common Stock (REVB)
Revelation Biosciences, Inc. Common Stock (REVB) has a 16-report earnings history dating back to May 17, 2022. Its average absolute post-earnings move is ±4.27%, and 43.8% of those reactions were positive. Its largest post-earnings gain was +25.15% (Nov 08, 2024) and its largest decline was -13.7% (May 10, 2024). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
16
Avg Abs. Movement
±4.27%
Positive %
43.8%
Negative %
56.2%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☽ POST | $1.03 | $1.03 | $1.01 | 800 | -0.5% | open_in_new |
| Feb 26, 2026 | ☽ POST | $1.36 | $1.36 | $1.32 | 1,485 | +0% | open_in_new |
| Nov 06, 2025 | ☽ POST | $0.98 | $1.01 | $1.01 | 3,069 | +0% | open_in_new |
| Aug 08, 2025 | ☀ PRE | $2.43 | $2.46 | $2.46 | 408 | -3.15% | open_in_new |
| May 08, 2025 | ☽ POST | $2.92 | $2.92 | $2.92 | 0 | +0% | open_in_new |
| Mar 06, 2025 | ☽ POST | $3.56 | $3.56 | $3.43 | 212 | -2.33% | open_in_new |
| Nov 08, 2024 | ☽ POST | $0.83 | $0.83 | $0.83 | 0 | +25.15% | open_in_new |
| Aug 09, 2024 | ☽ POST | $1.02 | $1.02 | $1.00 | 286 | -7.2% | open_in_new |
| May 10, 2024 | ☽ POST | $2.19 | $2.19 | $2.19 | 100 | -13.7% | open_in_new |
| Mar 22, 2024 | ☽ POST | $2.40 | $2.40 | $2.40 | 198 | +0% | open_in_new |
| Nov 13, 2023 | ☽ POST | $0.57 | $0.57 | $0.57 | 0 | +0% | open_in_new |
| Aug 11, 2023 | ☽ POST | $0.75 | $0.75 | $0.75 | 100 | -2.4% | open_in_new |
| May 22, 2023 | ☽ POST | $1.25 | $1.29 | $1.19 | 2,111 | -6.72% | open_in_new |
| Nov 10, 2022 | ☽ POST | $0.20 | $0.22 | $0.22 | 1,400 | -3.12% | open_in_new |
| Aug 17, 2022 | ☽ POST | $0.47 | $0.47 | $0.47 | 100 | +0% | open_in_new |
| May 17, 2022 | ☽ POST | $0.62 | $0.65 | $0.65 | 300 | -4.13% | open_in_new |
Earnings Count
16
Total earnings in dataset
Avg Abs. Movement
±4.27%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
2 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260601 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
Frequently asked about REVB earnings
When does Revelation Biosciences, Inc. Common Stock report earnings next? expand_more
Revelation Biosciences, Inc. Common Stock (REVB)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does REVB stock move after earnings? expand_more
Over 16 reports, REVB has moved an average of ±4.27% the session after earnings, closing higher 43.8% of the time.
What was REVB's biggest post-earnings move? expand_more
REVB's largest post-earnings gain on record was +25.15% on Nov 08, 2024, and its largest decline was -13.7% on May 10, 2024.
Where can I find Revelation Biosciences, Inc. Common Stock's SEC filings? expand_more
All of Revelation Biosciences, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right